NemaTerra SRL
NemaTerra reported total assets of €2.02m at the end of the 2025 financial year (annual accounts filed with the NBB on 15 Jun 2026).
The score of NemaTerra shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +4000 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
NemaTerra's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 15 Jun 2026
- Year ended 31 Dec 2024filed on 16 Jun 2025
- Year ended 31 Dec 2023filed on 26 Jun 2024
- Year ended 31 Dec 2022filed on 11 Oct 2023
- Year ended 31 Dec 2021filed on 16 Jun 2022
NemaTerra's financial analysis
- Solvency87.1%sector median: 61.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of NemaTerra
NemaTerra's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0683.893.649
- VAT number
- BE0683893649
- Peppol
- Registered · 0208:0683893649 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 31 Oct 2017
- Registered office
- 2280 Grobbendonk
- Latest accounts
- 2025 · filed on 15 Jun 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
NemaTerra (SRL) has been based in Grobbendonk since 2017, active in: research and experimental development on biotechnology. For 2025, it reports a net loss of 420,073 € and equity of €1.76m; its revenue is not published. Its solvency stands at 87.1%, above the median of its sector (61.7%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to NemaTerra
Companies in the same business, of comparable size and area, outside its group.
- Aphea.Bio Research and experimental development on natural sciences and engineering Ghent · balance sheet €16.2m
- Asterion Research & Development Research and experimental development on natural sciences and engineering Ghent · balance sheet €2.31m
- Inhatarget Therapeutics Research and experimental development on natural sciences and engineering Charleroi · balance sheet €2.16m
- SECOYA Technologies Manufacture of basic pharmaceutical products Ottignies-Louvain-la-Neuve · balance sheet €2.31m
- BiocSol Research and experimental development on natural sciences and engineering Mont-Saint-Guibert · balance sheet €5.75m
- Zomagen Biosciences Belgium Research and experimental development on natural sciences and engineering Ghent · balance sheet €1.83m
- Stam Agro Research and experimental development on natural sciences and engineering Dendermonde · balance sheet €1.86m
- Celyad Oncology Research and experimental development on natural sciences and engineering Mont-Saint-Guibert · balance sheet €4.03m
Frequently asked questions about NemaTerra
What is the revenue of NemaTerra?
NemaTerra files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of NemaTerra?
In Belgium, the VAT number is the company number prefixed with BE: BE0683893649 for NemaTerra, if the company is VAT-registered. Its company number (CBE) is 0683.893.649.
Where is the registered office of NemaTerra?
According to the CBE register, the registered office of NemaTerra is in 2280 Grobbendonk.
What is the equity of NemaTerra?
At the close of the 2025 financial year, the equity of NemaTerra amounts to 1,762,059 €, a solvency of 87.1% of total assets.
Who manages NemaTerra?
The register lists 4 active mandates at NemaTerra. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of NemaTerra
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →